throbber
Parenteral Nutrition
`
` Many sick newborn infants cannot obtain adequate nutrition via the
`GI tract and, thus, require parenteral nutritional (PN) support. In some, GI function is
`adequate to allow some feedings. In others, the GI tract may not function for days to
`weeks (
`, necrotizing enterocolitis, bowel anomalies), so the infant receives all
`nutrition parenterally (Total Parenteral Nutrition, TPN).
`
`Sick newborns usually have increased caloric requirements.
`Minimal caloric requirements to prevent catabolism are at least 40 kcal/kg/d.
`For growth, minimal requirements are 80 kcal/kg/d and protein intake of >2
`gm/kg/d. For adequate growth, aim for 100 kcal/kg/d and protein intake of 3
`g/kg/d for term infants and 3.5 g/kg/d for preterm infants.
`Nutrition support should be initiated within 3 days of birth and should include
`protein. A "starter TPN" solution is available to start TPN at arrival to the unit.
`Start PN when at least 30 cc/kg/d can be used for this route.
`Although growth can be obtained with PN, enteral feedings should be initiated as
`soon as feasible, because of risks associated with PN.
`
`route is used for partial or supplemental PN. This route is usually used for
`short-term nutritional support. Peripheral PN solutions cannot exceed 12.5% dextrose
`(D12.5) or 3.5% amino acids due to the risk of thrombophlebitis and should not contain
`calcium because of the serious complications resulting from extravasation of calcium.
` PN is delivered by a venous catheter with the tip in a central location (see the
`section on Peripherally Inserted Central Catheters, P. 31). This route is used for patients
`who require long-term nutritional support, usually TPN.
`
`Neonatal nutrition support literature supports early and aggressive nutrition support for
`the VLBW infant. Clinical research shows that protein is well tolerated in the first hours
`of life and recent studies suggest starting that protein source as soon as possible after
`
`136
`
`Eton Ex. 1045
`1 of 7
`
`

`

`birth with higher initial amounts is well tolerated. "Starter TPN" is now available on the
`unit to decrease the amount of time the infant is without a protein source.
`
`Parenteral Nutrition
`
`1. Target infants are <1200 grams or <30 weeks or those expected to require
`parental support based on diagnosis (eg. CDH, TEF, gastroschisis). The "starter"
`TPN may also be used if the patient specific prescribed TPN needs to be held for
`access issues (loss of PICC) or if the patient is made NPO and TPN needs to be
`started.
`2. 150 ml bags of D10AA3.5, no electrolytes are stocked in the ICN East
`refrigerator.
`3. The admitting MD/NNP writes the admit orders to initiate "starter" TPN as one of
`the IVF at 60-80 ml/kg/d. The starter TPN must be specified as D10WAA3.5 at
`__ml/hour.
`4. Maximum "starter" TPN amount is 100 ml/kg/day. Additional IVF will be
`ordered separately.
`5. For fluid restriction, the "starter" TPN can run at a lower rate but the protein
`intake will be lower than target.
`6. The admitting MD/NNP will also write the TPN order for the next bag, advancing
`as per ICN guidelines. An order to discontinue the "starter TPN" solution once the
`new TPN arrives will be written as well.
`
` include:
`
`1.
`
`is administered as a solution of amino acids, Premasol™, a preparation
`designed for pediatric patients. All infants in the ICN should receive Premasol™.
`Start amino acids at 2-3 g/kg/d, as much as possible depending on fluid
`allowance and access. The traditional step-wise advance of protein has not
`been found to be necessary and may be negatively affecting the infants'
`nutritional status. Advance by 0.5 gm/kg/d to goal as needed.
`Maximum is 3 g/kg/d in term infants and 3.5 g/kg/d in preterm infants.
`Include protein in you calorie count. Protein yields 4 kcal/g.
`
`Potential complications/risk include:
`Acidosis
`
`Elevated BUN
`
`
`Hyperammonemia
`Cholestasis with prolonged administration
`
`
`
`
`
` is administered as dextrose monohydrate.
`Start with 4-6 mg/kg/min or D10-D12.5. Alternatively, calculate the
`glucose infusion rate that the infant is already receiving and advance from
`there.
`
`137
`
`Eton Ex. 1045
`2 of 7
`
`

`

`Parenteral Nutrition
`
`Very preterm infants may not tolerate that much dextrose and may even
`need insulin as an infusion to achieve adequate caloric intake without
`hyperglycemia.
`Advance by 1-3 mg/kg/min daily to a maximum of 12 mg/kg/min (up to
`15 mg/kg/min in selected cases).
`Dextrose yields 3.4 kcal/g.
`Consult reverse side of TPN order sheet for maximal allowable
`dextrose/amino acid concentrations.
`Potential complications/risks include:
`Hyperglycemia or hypoglycemia
`Glycosuria and potential osmotic diuresis
`Cholestasis and/or hepatic steatosis with high caloric intake usually
`from long-term high concentration infusion.
` Intravenous lipid emulsions are essential components of TPN. They provide
`essential fatty acids and are a concentrated energy source critical for growth and
`development of infants not receiving enteral feedings. There are potential safety
`concerns regarding administration of lipid emulsions to very low birth weight infants and
`infants with hyperbilirubinemia, pulmonary hypertension and serious pulmonary disease.
`To maximize benefits of lipids and minimize their adverse effects, use the following
`guidelines: (a) provide sufficient lipids to prevent essential fatty acid deficiency; (b)
`monitor for evidence of lipid intolerance; (c) adjust lipid dose based on clinical status.
`
`A lipid intake of 0.25-0.5 g/kg/d is required to prevent essential fatty acid
`deficiency.
`
`ations of total fluid intake.
`
`Lipids yield 10 kcal/g.
`IV lipid preparations are available as a 20% soybean emulsion that yields 2
`kcal/mL.
`See Table below for starting and advancing lipids.
`Deliver IV lipids over 24 hours.
`Do not allow lipids to exceed 60% of total caloric intake.
`Potential complications/risks include:
`
`Hyperlipidemia
`Potential risk of kernicterus at low levels of unconjugated bilirubin because of
`displacement of bilirubin from albumin binding sites by free fatty
`acids. As a general rule, do not advance lipids beyond 0.5 g/kg/d until
`bilirubin is below threshold for phototherapy
`Potential increased risk or exacerbation of chronic lung disease
`Potential exacerbation of Persistent Pulmonary Hypertension (PPHN)
`Lipid overload syndrome with coagulopathy and liver failure
`
`138
`
`Eton Ex. 1045
`3 of 7
`
`

`

`Parenteral Nutrition
`
`
`
`DOL 3
`DOL 3
`DOL 3
`
` DOL 7
`DOL 4
`When status improves
`
`DOL 11
`DOL 9
`
`
`Preterm
`
`Term
`
`<1,500 g, stable
`1,500 g, stable
`.,
`Very unstable (
` bilirubin)
`severe RDS,
`No pulm. disease
`Severe pulm. disease,
`PPHN, MAS
`(DOL, day of life; pulm., pulmonary; PPHN, persistent pulmonary hypertension of newborn; MAS
`meconium aspiration syndrome)
`
`DOL 4
`DOL 3
`Consider DOL 7 When status improves
`
`DOL 9
`
`
`4.
` are stated on the parenteral nutrition order form and must be
`adjusted according to serum values and clinical condition. (See section of Fluids and
`Electrolytes, p. 56) Initial PN solutions may be started without added electrolytes. Add
`electrolytes gradually as the patient becomes more stable. Acetate is metabolized to
`- and is added to adjust acid-base status. It can be ordered maximize, minimize, or
`HCO3
`balance with chloride depending upon an infant's acid-base status.
`
` Preterm infants and term infants receiving long-term parenteral nutrition are
`at increased risk for bone demineralization and fractures. Calcium (Ca) and phosphorus
`(P) delivery should be maximized for all infants receiving PN.
`
`Calcium is only allowed if the TPN if the line is central. If only a peripheral line is
`available, add phosphorus to the TPN and give Ca gluconate separately.
`Only 1 mineral may be added if the solution also contains sodium or potassium. The
`maximum P=Total Cation X 0.6.
`Mark Premasol box.
`Determine current dose of calcium prescribed in mEq of elemental calcium/kg.
`(approximately 1 mEq Ca=2mg Calcium gluconate)
`If the current calcium gluconate dose significantly exceeds the goal amount, start calcium
`in the TPN at goal (as solubility allows) and give additional Ca gluconate boluses as
`needed monitoring ionized calcium. Wean off the boluses as tolerated.
`See table below for advancement. Try to keep a Ca (mEq) to P (mmol) ratio of 2:1.
`
`Check Premasol solubility table on back of TPN form.
`Advance as long as Ca <1.4. To treat a high Ca , increase the P. Be sure the
`patient isn’t receiving too much calcium (eg.Ca in the TPN and concurrent Ca
`gluconate boluses)
`Follow ionized calcium and weekly pediatric TPN panels.
`Do not start magnesium until the serum level is <2.5 mg/dL.
`
`Initiate
`Advance every 1-2 days
`Goal
`
`2 mEq/kg
`0.5 mEq/kg
`3 mEq/kg (preterm)
`2 mEq/kg (term)
`
`1 mmol/kg
`0.3-0.5 mmol/kg
`1.5 mmol/kg (preterm)
`1.2 mmol/kg (term)
`
`139
`
`Eton Ex. 1045
`4 of 7
`
`

`

`Parenteral Nutrition
`
`Preterm
`
`Term
`
`1.2-1.4
`
`1.2-1.3
`
`(mg/dL)
`8-11
`
`8-12
`
`6-8
`
`5-9.5
`
`2-2.5
`
`1.8-2.3
`
`include:
` are recommended as 0.2 mL/kg/d of trace element solution
`containing zinc, manganese, copper, and chromium.
`Preterm infants need additional zinc (300 mcg/kg/d) and selenium (2
`mcg/kg/d).
`Term infants need additional zinc (200 mcg/kg/d) and selenium (2
`mcg/kg/d).
`,. direct bilirubin >2.5 mg/dL),
`For infants with cholestasis (
`discontinue the trace element solution and give:
`Zinc 400 mcg/kg/d TOTAL (preterm infants)
`300 mcg/kg/d TOTAL (term infants)
`Chromium 0.2 mcg/kg/d
`Selenium 2 mcg/kg/d
`Discontinue selenium with patients on renal dialysis.
`Pediatric multivitamins are recommended as 2.0 mL/kg/d up to a
`maximum of 5 mL/kg/d. Components are listed on the PN order form.
`(1 unit/mL) is added to all central venous lines and to all peripheral
`infusions running at <2 mL/hr in order to maintain catheter patency.
` of infants receiving parenteral nutrition should include:
`
`Test
`Electrolytes,
`BUN/creatinine
`Chemstrip/glucose
`
`Calcium, ionized
`Total calcium, phosphorus,
`magnesium, bilirubin (T/D),
`ALT, alkaline phosphatase, GGT,
`albumin
`Triglycerides
`
`Initial
`Daily
`
`q6hr-daily
`
`daily
`Baseline
`
`When stable
`2-3x/week
`
`Daily, more frequently when
`changing CHO
`2-3x/week
`weekly
`
`When lipid infusion reaches 1.5 g
`fat/kg/d and
`3 g fat/kg/d
`CBC/Diff and platelets
`
`weekly
`Note: The Pediatric TPN panel includes all of the above laboratory tests except the CBC/diff, platelets and
`glucose. It requires 0.4 cc of blood in each of 2 microtainer tubes (i.e., 0.8 cc total). It is usually drawn on
`Mondays with additional individual labs as needed or suggested above.
`
`weekly
`
`140
`
`Eton Ex. 1045
`5 of 7
`
`

`

` of infants receiving PN is essential, including weekly
`measurements of head circumference. Measurements (weight, length and head
`circumference) should be plotted on standard post-natal growth charts.
`
`Parenteral Nutrition
`
`When the patient is tolerating >50 ml/kg/day of feedings, the TPN should be gradually
`tapered off. The table below maintains a minimum calorie intake of 100 kcal/kg/day and
`>2 grams protein/kg/day. These guidelines may be used for both the preterm and term
`infant, although the term infant may not need the concentrated breastmilk/formula.
`
`Directions: Determine total fluid allowance for the day. Write the TPN for the suggested
`volume and substrate amounts as indicated by the feeding volume. Use the lower end of
`the feeding volume range specified for your calculations. The suggested amounts of the
`CHO/protein/fat should be compatible except if the patient is significantly fluid
`restricted. The calcium and phosphorus must also be decreased for solubility reasons.
`Specify an IV+po order to keep total fluid intake at the prescribed amount.
`
`Feed
`Volume
`(cc/kg)
`0-49
`50-74
`75-99
`100-120
`120-150
`150-160
`
`PN Substrate
`(CHO/prot/fat)1
`
`12/3.5/3
`10/2.5/2
`8/2/1.5
`8/2/1
`None
`None
`
`IV+po
`Volume
`(cc/kg)
`100-140
`120-140
`130-140
`130-150
`NA
`NA
`
`Total TPN
`Volume
`(cc/kg)2,3
`100-140
`70-90
`55-654
`554
`None
`None
`
`MBM/formula
`Ca/P
`concentration
`(mEq/
`mmol)5
`(kcal/oz)
`20
`3/1.5
`20
`2.45/1.2
`1.75/0.85 20
`1.75/0.85 22
`N/A
`22-24
`N/A
`24
`
`1. mg CHO/kg/min, g prot/kg, g fat/kg
`2. Total TPN volume= (IV+po goal)-(lower end of indicated feed volume range)
`3.
`4. Keep the minimum dextrose/amino acid volume at 50 cc/kg for ordering purposes
`5. Amount per kg as ordered on the TPN form
`
`: PN may be stopped when the
`infant is tolerating 100-120 cc/kg of enteral feedings or is receiving 25 cc/kg/d of PN.
`The rate of dextrose administration should be tapered to prevent rebound hypoglycemia.
`Chemstrips should be done q6h. Newborns need a slower tapering than older children
`and require continued monitoring of glucose after the solution has been stopped. Lipids
`may be stopped without tapering. If the PN catheter clots or infiltrates, start another IV
`with dextrose concentration 12.5% depending on the current glucose concentration. The
`“Starter TPN” (D10WAA3.5) may also be used to maintain protein intake until a new
`bag arrives.
`
`141
`
`Eton Ex. 1045
`6 of 7
`
`

`

`Parenteral Nutrition
`
`For additional information regarding PN:
`Please see the following web site:
`http://yew.ucsf.edu/DIAS/parenteral_nutr_guide_Neo_ped.htm
`Request consult from Nutrition Services: 353-1461 or 353-1814, Ext. 1; on
`weekends, page the Nutritionist on call at 443-4822.
`
`142
`
`Eton Ex. 1045
`7 of 7
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket